ORLANDO, Florida — Use of cannabis is common in patients with multiple sclerosis (MS), especially for the treatment of MS-related

Updated European guidelines on the treatment of patients with multiple sclerosis (MS) have been announced, and include a recommendation for

MRI results may not be effective at indicating disability for patients with secondary progressive multiple sclerosis (SPMS), new research suggests.

Differences in lesion evolution may help neurologists distinguish between multiple sclerosis (MS) and other demyelinating disorders in new findings that

Oral evobrutinib, an investigational highly selective Bruton’s tyrosine kinase inhibitor, may have a beneficial effect on reducing nerve damage in